roche
Entity, reached from Hormuz.
- Evidence
- 165 documents · 60 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 12 Jun 2026, last seen 10 Oct 2026
- Measured
- 26% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- AllSci News · 2026-10-09 · Roche's Tecentriq wins 12th FDA indication, for stage III colon cancer (opens the source in a new tab)
- Endpoints News · 2026-10-08 · Zealand, Roche topline a Phase 2 study for amylin drug, though Lilly remains an obstacle (opens the source in a new tab)
- STAT News · 2026-10-08 · STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines (opens the source in a new tab)
- STAT News · 2026-10-08 · STAT+: Roche goes beyond licensing in deal with Chinese biotech (opens the source in a new tab)
- Endpoints News · 2026-10-08 · Roche does fourth China deal since August, teaming with Defand on degraders (opens the source in a new tab)
- Fierce Pharma · 2026-10-07 · AbbVie, Genmab score first-line DLBCL win for Epkinly, teeing up challenge to Roche's Polivy (opens the source in a new tab)
- Endpoints News · 2026-10-06 · Roche enlists Alector in Parkinson's deal, paying $100M upfront (opens the source in a new tab)
- Clinical Trials Arena · 2026-10-02 · EASD 2026: Roche’s enicepatide shows 22.7% placebo-adjusted weight loss at 48 weeks (opens the source in a new tab)
- Medical Device Network · 2026-10-01 · Roche’s TIB MOLBIOL introduces in vitro newborn screening test kit (opens the source in a new tab)
- Fierce Biotech · 2026-10-01 · Roche launches simultaneous screening test for SMA, SCID and SCD (opens the source in a new tab)
1 more on file, counted in the evidence above.
What is claimed about it
- Single source: Reported by one source so far.
- Could not check: We could not count this claim's sources, so we do not say how well it is supported.
- AbbVie, Genmab score first-line DLBCL win for Epkinly, teeing up challenge to Roche's Polivy Could not check · a claim about it
- STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines Single source · a claim about it
Situations it is named in
Who it moves with
- co-mentioned with fda (55 documents)seen together
- co-mentioned with novartis (43 documents)seen together
- co-mentioned with astrazeneca (35 documents)seen together
- co-mentioned with eli lilly (31 documents)seen together
- co-mentioned with genentech (28 documents)seen together
- co-mentioned with pfizer (27 documents)seen together
- co-mentioned with china (27 documents)seen together
- co-mentioned with amgen (25 documents)seen together